| 000 | 01393 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517203813.0 | ||
| 264 | 0 | _c20190501 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1875-6190 | ||
| 024 | 7 |
_a10.2174/1570159X16666180302115032 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJamwal, Sumit | |
| 245 | 0 | 0 |
_aInsight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson's Disease and Huntington's Disease: A Review. _h[electronic resource] |
| 260 |
_bCurrent neuropharmacology _c2019 |
||
| 300 |
_a165-175 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAcetylcholine _xmetabolism |
| 650 | 0 | 4 |
_aAdenosine _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBasal Ganglia _xmetabolism |
| 650 | 0 | 4 |
_aCannabinoids _xmetabolism |
| 650 | 0 | 4 |
_aCorpus Striatum _xmetabolism |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aGlutamic Acid _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHuntington Disease _xmetabolism |
| 650 | 0 | 4 |
_aNeuropeptides _xmetabolism |
| 650 | 0 | 4 |
_aParkinson Disease _xmetabolism |
| 650 | 0 | 4 | _aSynaptic Transmission |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xmetabolism |
| 700 | 1 | _aKumar, Puneet | |
| 773 | 0 |
_tCurrent neuropharmacology _gvol. 17 _gno. 2 _gp. 165-175 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1570159X16666180302115032 _zAvailable from publisher's website |
| 999 |
_c28153011 _d28153011 |
||